Patent · US Active

Post-translation modified cardiac troponin T as a biomarker of a risk for heart failure

US8986936B2 · kind B2 · utility

0Cited by

1References

2Claims

0Family size

Assignees

INSERM (INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE) · FR
INSTITUT PASTEUR DE LILLE · FR
Le Centre Hospitalier Regional Universitaire de Lille · FR
UNIVERSITE DE ROUEN · FR

Inventors

Florence Pinet · Paris, FR
Paul Mulder · Rouen, FR
Christophe Bauters · Lille, FR
Vincent Richard · Paris, FR

Key dates

Filing date	May 20, 2010
Grant date	Mar 24, 2015
Priority date	—
Expiry date	Oct 1, 2031

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY10S436/811
WIPO fieldMeasurement
WIPO sectorInstruments

Abstract

The present invention relates to methods and kits for the prediction of risk for heart failure using post-translation modified forms of cardiac troponin T as a biomarker.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.